Products

AdvaTab® Temazepam ODT

A A A

Convenient ODT treatment for insomnia may be taken as needed, without water.


Therapeutic Category Sleep Aid
Indication
  • Short-term treatment of insomnia
Available Dosage Strength(s)
  • 7.5 mg
  • 15 mg
  • 22.5 mg
  • 30 mg
Product Description
  • ODT formulation of temazepam, a benzodiazepine hypnotic agent
Eurand Technology
Data
  • Demonstrated clinically bioequivalent to Restoril™(temazepam) Capsules USP, marketed in the U.S. by Mallinckrodt Pharmaceuticals
  • Successfully prescribed to treat sleep disorders for more than two decades1
Advantages
  • Consumer preferred, easy-to-swallow dosage form
  • Administered as needed, without water
  • Smooth, pleasant taste and mouth feel via proprietary microencapsulation technology
  • Disintegrates rapidly in just 15-30 seconds
  • Protected by issued and pending U.S. and international patents
Temazepam

AdvaTab® Temazepam has been clinically demonstrated as bioequivalent to the currently marketed U.S. brand, Restoril™(temazepam) Capsules USP.

This information is provided solely for the purpose of the evaluation of business opportunities by potential collaboration partners. The information is based on currently existing data and marketing authorizations in a number of jurisdictions and should not be assumed to be approved by regulatory authorities in any individual country. Consumers should consult with their individual physician for product information and should not rely upon any information provided here.

1www.restoril.com
Restoril™ is a registered trademark of Mallinckrodt, Inc.

Sleep Aid Products

More Information

For more information, contact Eurand at partners@eurand.com or +1-267-759-9340

contact Eurand +